Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-25-037259 General Corporate
Debt relative to revenue 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
183.36% · OPTIONAL · VALID
Capex intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.75% · OPTIONAL · VALID
Operating cash generation 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-1.75% · OPTIONAL · VALID
Share-count growth 0th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.shares_outstanding
-3.17% · CORE · VALID
Revenue growth 40th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
9.41% · CORE · VALID
Inventory pressure 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
43.15% · OPTIONAL · VALID
Gross margin 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
38.60% · CORE · VALID
Operating margin 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
16.27% · CORE · VALID
R&D intensity 15th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.98% · OPTIONAL · VALID
SBC intensity 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.20% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 217.85%
Current 183.36%
Delta -34.50% Capex Intensity Decreased
Previous 2.61%
Current 1.75%
Delta -0.85% Cash Generation Decreased
Previous 7.44%
Current -1.75%
Delta -9.19% Dilution Decreased
Previous -0.83%
Current -3.17%
Delta -2.34% Growth Increased
Previous -7.47%
Current 9.41%
Delta 16.87% Inventory Pressure Decreased
Previous 46.24%
Current 43.15%
Delta -3.09% Margin Decreased
Previous 38.76%
Current 38.60%
Delta -0.16% Profitability Increased
Previous 16.06%
Current 16.27%
Delta 0.21% R And D Intensity Decreased
Previous 2.16%
Current 1.98%
Delta -0.18% Sbc Intensity Increased
Previous 1.05%
Current 1.20%
Delta 0.15% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.